Company intelligence / Profile preview

Cryoport

Brentwood, Tennessee, United Statescryoportinc.com ↗
Ownership
Public · CYRX
Employees
~700
Development stage
Other
01

Overview

Cryoport supports over 650 active clinical trials and at least ten commercial cell and gene therapies with its temperature-controlled logistics platforms. The company enables reliable global transport and storage of sensitive biological materials such as cell therapies, immunotherapies, stem cells, reproductive cells/embryos/gametes, animal health products, vaccines and more. It does not itself conduct clinical trials for drugs but underpins the success of advanced therapy programs by ensuring material integrity throughout the supply chain. No direct clinical results as it does not sponsor drug development.

Modalities
Device (cryogenic storage systems)Service (temperature-controlled logistics and biostorage)Not directly involved in therapeutic modalities like small molecules or biologics development
Industry
Non-Drug Biotech
02

Partnerships

Syneos Health partnership for integrated cell therapy supply chains via IntegriCell™ platformCell Matters collaboration to standardize autologous cell therapy transport processes
03

Financials

Market cap
$812.9M
Total revenue
$176.2M
Enterprise value
$651.4M

Beyond the preview

Go deeper on Cryoport.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryoport.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call